Skip to content

Social Determinants of Health in Diabetes Outcomes

Social Determinants of Health as Explanatory Factors for Ethnic Disparities in Diabetes Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01749345
Enrollment
650
Registered
2012-12-13
Start date
2012-07-31
Completion date
2014-08-31
Last updated
2018-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Brief summary

This is a cross-sectional study of six hundred adults with type 2 diabetes, (300 White and 300 African-American) who will be recruited from two primary care sites to determine how social determinants of health impact diabetes outcomes. The first aim is to investigate the role of psychosocial factors and SES on diabetes care processes and outcomes. The second aim is to investigate the influence of community and neighborhood characteristics on diabetes care processes and outcomes. Finally, we will examine the contribution of social determinants of health to ethnic differences in diabetes care processes and outcomes. Clinical and metabolic measures will be abstracted from the electronic medical records. Outcome variables include hemoglobin A1c, blood pressure, LDL-Cholesterol and quality of life.

Interventions

None listed

Sponsors

Ralph H. Johnson VA Medical Center
CollaboratorFED
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of type 2 diabetes * Able to communicate in English

Exclusion criteria

* Mental confusion on interview suggesting significant dementia * Alcohol or drug abuse/dependency * Active psychosis or acute mental disorder

Design outcomes

Primary

MeasureTime frame
HbA1CWithin 3 months prior to the assessment
Quality of lifeWithin a month of completely the assessment

Secondary

MeasureTime frame
Blood pressureMost recent to assessment date
Low density lipoprotein (LDL) CholesterolMost recent to assessment date

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026